Portfolio Holdings Detail for ISIN IE00BYZK4776
Stock Name / Fund iShares Healthcare Innovation UCITS ETF USD (Acc)
Issuer Blackrock
Entity holding fund iShares IV Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF Ticker DRDR(GBX) LSE
ETF Ticker 2B78(EUR) F
ETF Ticker 2B78.DE(EUR) CXE
ETF Ticker DRDR.LS(GBX) CXE
ETF Ticker HEAL.AS(EUR) CXE
ETF Ticker HEAL.LS(USD) CXE
ETF Ticker HEALz(USD) CXE
ETF Ticker HEAL(EUR) ETF Plus
ETF Ticker DRDR.L(GBP) LSE

Holdings detail for CDNA

Stock Name	Caredx Inc
Ticker	CDNA(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US14167L1035
LEI	549300NQOFKL9NON0U06

Show aggregate CDNA holdings

News associated with CDNA

CareDx, Inc. (NASDAQ:CDNA) Receives $25.50 Average PT from Analysts: Shares of CareDx, Inc. (NASDAQ:CDNA – Get Free Report) have earned a consensus rating of “Moderate Buy” from the seven brokerages that are covering the firm, Marketbeat reports. Three research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 1 year price target […] - 2025-09-16 02:46:50
Implied XBI Analyst Target Price: $142: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-15 07:18:21
CareDx (NASDAQ:CDNA) Coverage Initiated by Analysts at William Blair: William Blair assumed coverage on shares of CareDx (NASDAQ:CDNA – Free Report) in a research note published on Tuesday, MarketBeat Ratings reports. The firm issued a market perform rating on the stock. Several other research analysts have also commented on the company. Stephens reiterated an “overweight” rating and issued a $40.00 target price on shares […] - 2025-08-27 03:00:54
Brokerages Set CareDx, Inc. (NASDAQ:CDNA) PT at $27.67: CareDx, Inc. (NASDAQ:CDNA – Get Free Report) has been given an average rating of “Moderate Buy” by the six analysts that are presently covering the firm, Marketbeat Ratings reports. Two analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 1 year price target […] - 2025-08-22 03:12:55
Wells Fargo & Company Has Lowered Expectations for CareDx (NASDAQ:CDNA) Stock Price: CareDx (NASDAQ:CDNA – Free Report) had its price target trimmed by Wells Fargo & Company from $19.00 to $14.00 in a report published on Friday,Benzinga reports. The firm currently has an equal weight rating on the stock. CDNA has been the topic of a number of other reports. HC Wainwright reaffirmed a “neutral” rating and […] - 2025-08-11 04:50:51
Federated Hermes Inc. Increases Holdings in CareDx, Inc. (NASDAQ:CDNA): Federated Hermes Inc. grew its holdings in shares of CareDx, Inc. (NASDAQ:CDNA – Free Report) by 29.8% in the first quarter, Holdings Channel reports. The institutional investor owned 131,861 shares of the company’s stock after purchasing an additional 30,284 shares during the period. Federated Hermes Inc.’s holdings in CareDx were worth $2,341,000 as of its […] - 2025-08-06 05:13:10
CareDx, Inc. (NASDAQ:CDNA) Receives Average Rating of “Moderate Buy” from Brokerages: CareDx, Inc. (NASDAQ:CDNA – Get Free Report) has received an average rating of “Moderate Buy” from the six research firms that are presently covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 1-year price target among […] - 2025-07-30 04:24:54
Craig Hallum Cuts CareDx (NASDAQ:CDNA) Price Target to $26.00: CareDx (NASDAQ:CDNA – Free Report) had its price target reduced by Craig Hallum from $40.00 to $26.00 in a research note published on Friday,Benzinga reports. They currently have a buy rating on the stock. CDNA has been the subject of several other research reports. HC Wainwright reiterated a “neutral” rating and issued a $25.00 target […] - 2025-07-21 04:55:01
CareDx, Inc. (NASDAQ:CDNA) Receives Average Rating of “Moderate Buy” from Brokerages: Shares of CareDx, Inc. (NASDAQ:CDNA – Get Free Report) have received a consensus rating of “Moderate Buy” from the six ratings firms that are covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12 month […] - 2025-06-30 02:34:54
535,341 Shares in CareDx, Inc. (NASDAQ:CDNA) Bought by Chevy Chase Trust Holdings LLC: Chevy Chase Trust Holdings LLC acquired a new position in CareDx, Inc. (NASDAQ:CDNA – Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 535,341 shares of the company’s stock, valued at approximately $9,502,000. Chevy Chase Trust Holdings LLC […] - 2025-06-27 05:36:54
CareDx (NASDAQ:CDNA) Share Price Crosses Above Fifty Day Moving Average Following Insider Selling: CareDx, Inc. (NASDAQ:CDNA – Get Free Report)’s share price crossed above its 50-day moving average during trading on Monday after an insider bought additional shares in the company. The stock has a 50-day moving average of $17.54 and traded as high as $19.23. CareDx shares last traded at $19.07, with a volume of 777,225 shares. […] - 2025-06-18 02:10:52
Bank of America Corp DE Sells 300,261 Shares of CareDx, Inc (NASDAQ:CDNA): Bank of America Corp DE reduced its stake in CareDx, Inc (NASDAQ:CDNA – Free Report) by 88.2% during the fourth quarter, HoldingsChannel.com reports. The fund owned 40,065 shares of the company’s stock after selling 300,261 shares during the quarter. Bank of America Corp DE’s holdings in CareDx were worth $858,000 at the end of the […] - 2025-06-09 04:16:51
Wellington Management Group LLP Trims Stake in CareDx, Inc (NASDAQ:CDNA): Wellington Management Group LLP trimmed its stake in CareDx, Inc (NASDAQ:CDNA – Free Report) by 14.6% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 165,362 shares of the company’s stock after selling 28,360 shares during the period. Wellington Management Group LLP’s holdings […] - 2025-06-05 05:36:55
Public Employees Retirement System of Ohio Has $1.15 Million Holdings in CareDx, Inc (NASDAQ:CDNA): Public Employees Retirement System of Ohio lifted its position in shares of CareDx, Inc (NASDAQ:CDNA – Free Report) by 6.5% during the 4th quarter, HoldingsChannel reports. The fund owned 53,672 shares of the company’s stock after purchasing an additional 3,287 shares during the period. Public Employees Retirement System of Ohio’s holdings in CareDx were worth […] - 2025-06-04 04:56:49
Mackenzie Financial Corp Invests $631,000 in CareDx, Inc (NASDAQ:CDNA): Mackenzie Financial Corp bought a new position in shares of CareDx, Inc (NASDAQ:CDNA – Free Report) in the 4th quarter, Holdings Channel reports. The fund bought 29,486 shares of the company’s stock, valued at approximately $631,000. Other hedge funds have also made changes to their positions in the company. Thompson Davis & CO. Inc. grew […] - 2025-06-03 05:31:06
Nuveen Asset Management LLC Acquires 60,050 Shares of CareDx, Inc (NASDAQ:CDNA): Nuveen Asset Management LLC grew its holdings in shares of CareDx, Inc (NASDAQ:CDNA – Free Report) by 15.5% in the fourth quarter, HoldingsChannel reports. The fund owned 448,113 shares of the company’s stock after purchasing an additional 60,050 shares during the quarter. Nuveen Asset Management LLC’s holdings in CareDx were worth $9,594,000 as of its […] - 2025-05-29 04:54:51
State of Wyoming Acquires Shares of 4,228 CareDx, Inc (NASDAQ:CDNA): State of Wyoming acquired a new stake in CareDx, Inc (NASDAQ:CDNA – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 4,228 shares of the company’s stock, valued at approximately $91,000. Several other large investors also recently bought and […] - 2025-05-28 05:15:06
Deutsche Bank AG Decreases Stock Position in CareDx, Inc (NASDAQ:CDNA): Deutsche Bank AG lowered its stake in CareDx, Inc (NASDAQ:CDNA – Free Report) by 15.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 126,692 shares of the company’s stock after selling 23,401 shares during the period. Deutsche Bank AG’s holdings in […] - 2025-05-22 04:45:00
CareDx, Inc (NASDAQ:CDNA) Shares Sold by Jane Street Group LLC: Jane Street Group LLC cut its stake in shares of CareDx, Inc (NASDAQ:CDNA – Free Report) by 19.1% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 123,729 shares of the company’s stock after selling 29,167 shares during the quarter. Jane Street […] - 2025-05-15 05:10:51
Hsbc Holdings PLC Has $365,000 Stock Holdings in CareDx, Inc (NASDAQ:CDNA): Hsbc Holdings PLC increased its holdings in shares of CareDx, Inc (NASDAQ:CDNA – Free Report) by 6.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 17,131 shares of the company’s stock after purchasing an additional 1,109 shares during the period. Hsbc Holdings PLC’s […] - 2025-05-09 06:50:49
Stephens Reiterates Overweight Rating for CareDx (NASDAQ:CDNA): CareDx (NASDAQ:CDNA – Get Free Report)‘s stock had its “overweight” rating reissued by investment analysts at Stephens in a research report issued on Monday,Benzinga reports. They currently have a $40.00 price objective on the stock. Stephens’ price objective would suggest a potential upside of 182.09% from the stock’s previous close. A number of other analysts […] - 2025-05-07 04:58:47
CareDx (NASDAQ:CDNA) Receives “Neutral” Rating from HC Wainwright: CareDx (NASDAQ:CDNA – Get Free Report)‘s stock had its “neutral” rating restated by stock analysts at HC Wainwright in a report released on Monday,Benzinga reports. They presently have a $25.00 price objective on the stock. HC Wainwright’s price objective would suggest a potential upside of 76.30% from the stock’s previous close. CDNA has been the […] - 2025-05-07 02:58:47
MetLife Investment Management LLC Has $664,000 Position in CareDx, Inc (NASDAQ:CDNA): MetLife Investment Management LLC grew its position in shares of CareDx, Inc (NASDAQ:CDNA – Free Report) by 7.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 31,034 shares of the company’s stock after purchasing an additional 2,134 shares during the quarter. MetLife Investment […] - 2025-05-05 06:01:03
CareDx, Inc (NASDAQ:CDNA) Shares Purchased by Barclays PLC: Barclays PLC raised its position in CareDx, Inc (NASDAQ:CDNA – Free Report) by 13.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 112,076 shares of the company’s stock after acquiring an additional 13,571 shares during the quarter. Barclays […] - 2025-05-01 05:14:55
Bank of Montreal Can Decreases Stock Holdings in CareDx, Inc (NASDAQ:CDNA): Bank of Montreal Can cut its holdings in CareDx, Inc (NASDAQ:CDNA – Free Report) by 97.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,629 shares of the company’s stock after selling 382,190 shares during the period. […] - 2025-04-25 04:36:52
Invesco Ltd. Acquires 51,160 Shares of CareDx, Inc (NASDAQ:CDNA): Invesco Ltd. raised its stake in shares of CareDx, Inc (NASDAQ:CDNA – Free Report) by 3.5% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,514,850 shares of the company’s stock after purchasing an additional 51,160 shares during the period. Invesco Ltd. […] - 2025-04-18 05:18:50
Geode Capital Management LLC Acquires 6,539 Shares of CareDx, Inc (NASDAQ:CDNA): Geode Capital Management LLC raised its position in CareDx, Inc (NASDAQ:CDNA – Free Report) by 0.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,234,263 shares of the company’s stock after acquiring an additional 6,539 shares during the period. Geode […] - 2025-04-18 04:34:51
KLP Kapitalforvaltning AS Makes New $208,000 Investment in CareDx, Inc (NASDAQ:CDNA): KLP Kapitalforvaltning AS acquired a new stake in shares of CareDx, Inc (NASDAQ:CDNA – Free Report) in the 4th quarter, Holdings Channel.com reports. The institutional investor acquired 9,700 shares of the company’s stock, valued at approximately $208,000. A number of other institutional investors and hedge funds have also made changes to their positions in CDNA. […] - 2025-04-08 05:44:59
Corebridge Financial Inc. Sells 1,897 Shares of CareDx, Inc (NASDAQ:CDNA): Corebridge Financial Inc. decreased its position in CareDx, Inc (NASDAQ:CDNA – Free Report) by 7.0% during the fourth quarter, Holdings Channel reports. The fund owned 25,138 shares of the company’s stock after selling 1,897 shares during the period. Corebridge Financial Inc.’s holdings in CareDx were worth $538,000 as of its most recent filing with the […] - 2025-04-08 04:27:02
CareDx, Inc (NASDAQ:CDNA) Shares Sold by Thrivent Financial for Lutherans: Thrivent Financial for Lutherans lessened its stake in CareDx, Inc (NASDAQ:CDNA – Free Report) by 28.8% in the fourth quarter, Holdings Channel reports. The institutional investor owned 57,939 shares of the company’s stock after selling 23,392 shares during the quarter. Thrivent Financial for Lutherans’ holdings in CareDx were worth $1,240,000 as of its most recent […] - 2025-04-01 04:38:49

iShares Healthcare Innovation UCITS ETF USD (Acc) CDNA holdings

Date	Number of CDNA Shares Held	Base Market Value of CDNA Shares	Local Market Value of CDNA Shares	Change in CDNA Base Value	Current Price per CDNA Share Held	Previous Price per CDNA Share Held
2025-11-11 (Tuesday)	63,265	USD 1,061,587	USD 1,061,587	USD 5,061	USD 16.78	USD 16.7
2025-11-10 (Monday)	63,265	USD 1,056,526	USD 1,056,526	USD 68,327	USD 16.7	USD 15.62
2025-11-07 (Friday)	63,265	USD 988,199	USD 988,199	USD 38,591	USD 15.62	USD 15.01
2025-11-06 (Thursday)	63,265	USD 949,608	USD 949,608	USD -96,162	USD 15.01	USD 16.53
2025-11-05 (Wednesday)	63,265	USD 1,045,770	USD 1,045,770	USD 127,162	USD 16.53	USD 14.52
2025-11-04 (Tuesday)	63,265	USD 918,608	USD 918,608	USD -15,816	USD 14.52	USD 14.77
2025-11-03 (Monday)	63,265	USD 934,424	USD 934,424	USD -14,551	USD 14.77	USD 15
2025-10-31 (Friday)	63,265	USD 948,975	USD 948,975	USD 33,530	USD 15	USD 14.47
2025-10-30 (Thursday)	63,265	USD 915,445	USD 915,445	USD 12,021	USD 14.47	USD 14.28
2025-10-29 (Wednesday)	63,265	USD 903,424	USD 903,424	USD -24,674	USD 14.28	USD 14.67
2025-10-28 (Tuesday)	63,265	USD 928,098	USD 928,098	USD 10,123	USD 14.67	USD 14.51
2025-10-27 (Monday)	63,265	USD 917,975	USD 917,975	USD -29,102	USD 14.51	USD 14.97

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of CDNA by Blackrock for IE00BYZK4776

Show aggregate share trades of CDNA

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-10-24 SELL -542 14.970 15.130 15.114 USD -8,192 19.34 Profit of 2,291 on sale
2025-09-11 BUY 273 13.530 13.797 13.770 USD 3,759 19.91
2025-07-08 SELL -270 19.250 19.380 19.367 USD -5,229 20.34 Profit of 264 on sale
2025-06-24 SELL -257 18.880 19.435 19.379 USD -4,981 20.42 Profit of 267 on sale
2025-06-23 BUY 3,507 18.950 19.200 19.175 USD 67,247 20.43
2025-06-11 SELL -256 20.080 20.390 20.359 USD -5,212 20.51 Profit of 38 on sale
2025-05-30 SELL -256 16.990 17.070 17.062 USD -4,368 20.63 Profit of 914 on sale
2025-05-21 BUY 256 17.050 17.600 17.545 USD 4,492 20.84
2025-05-14 SELL -1,530 16.020 16.630 16.569 USD -25,351 20.98 Profit of 6,750 on sale
2025-04-30 SELL -255 16.880 17.985 17.875 USD -4,558 21.52 Profit of 929 on sale
2025-04-28 SELL -255 18.250 18.710 18.664 USD -4,759 21.59 Profit of 745 on sale
2025-04-25 SELL -255 18.480 18.520 18.516 USD -4,722 21.62 Profit of 791 on sale
2025-04-11 SELL -1,548 18.810 18.910 18.900 USD -29,257 21.91 Profit of 4,666 on sale
2025-04-08 SELL -771 16.960 18.405 18.261 USD -14,079 22.04 Profit of 2,915 on sale
2025-04-07 SELL -556 17.720 18.670 18.575 USD -10,328 22.09 Profit of 1,955 on sale
2025-03-31 SELL -514 17.750 17.870 17.858 USD -9,179 22.30 Profit of 2,281 on sale
2025-03-21 SELL -510 19.320 19.360 19.356 USD -9,872 22.57 Profit of 1,638 on sale
2025-03-12 SELL -260 18.920 19.030 19.019 USD -4,945 22.94 Profit of 1,020 on sale
2025-02-28 SELL -259 22.150 22.230 22.222 USD -5,755 23.34 Profit of 290 on sale
2025-02-25 BUY 259 20.890 21.290 21.250 USD 5,504 23.46
2025-02-20 SELL -258 23.380 24.560 24.442 USD -6,306 23.52 Loss of -239 on sale
2025-02-19 BUY 516 24.700 25.150 25.105 USD 12,954 23.49
2025-02-18 BUY 258 24.490 25.550 25.444 USD 6,565 23.48
2024-12-30 SELL -493 21.180 21.350 21.333 USD -10,517 23.65 Profit of 1,144 on sale
2024-12-06 SELL -253 25.040 25.500 25.454 USD -6,440 23.56 Loss of -480 on sale
2024-12-04 SELL -253 25.920 26.370 26.325 USD -6,660 23.44 Loss of -730 on sale
2024-12-03 SELL -506 24.960 25.690 25.617 USD -12,962 23.39 Loss of -1,128 on sale
2024-11-21 SELL -258 22.580 22.850 22.823 USD -5,888 22.85 Profit of 6 on sale
2024-11-20 SELL -265 22.370 22.540 22.523 USD -5,969 22.87 Profit of 93 on sale
2024-11-19 SELL -265 22.060 22.300 22.276 USD -5,903 22.92 Profit of 171 on sale
2024-11-18 SELL -1,020 21.560 22.035 21.987 USD -22,427 23.01 Profit of 1,038 on sale
2024-11-12 SELL -255 23.320 23.960 23.896 USD -6,093 22.98 Loss of -232 on sale
2024-11-07 SELL -255 23.880 24.240 24.204 USD -6,172 22.86 Loss of -342 on sale
2024-11-05 SELL -510 22.900 23.364 23.318 USD -11,892 22.83 Loss of -249 on sale
2024-10-28 SELL -255 22.890 23.640 23.565 USD -6,009 22.99 Loss of -146 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-10-24	SELL	-542	14.970	15.130	15.114	USD -8,192	19.34 Profit of 2,291 on sale
2025-09-11	BUY	273	13.530	13.797	13.770	USD 3,759	19.91
2025-07-08	SELL	-270	19.250	19.380	19.367	USD -5,229	20.34 Profit of 264 on sale
2025-06-24	SELL	-257	18.880	19.435	19.379	USD -4,981	20.42 Profit of 267 on sale
2025-06-23	BUY	3,507	18.950	19.200	19.175	USD 67,247	20.43
2025-06-11	SELL	-256	20.080	20.390	20.359	USD -5,212	20.51 Profit of 38 on sale
2025-05-30	SELL	-256	16.990	17.070	17.062	USD -4,368	20.63 Profit of 914 on sale
2025-05-21	BUY	256	17.050	17.600	17.545	USD 4,492	20.84
2025-05-14	SELL	-1,530	16.020	16.630	16.569	USD -25,351	20.98 Profit of 6,750 on sale
2025-04-30	SELL	-255	16.880	17.985	17.875	USD -4,558	21.52 Profit of 929 on sale
2025-04-28	SELL	-255	18.250	18.710	18.664	USD -4,759	21.59 Profit of 745 on sale
2025-04-25	SELL	-255	18.480	18.520	18.516	USD -4,722	21.62 Profit of 791 on sale
2025-04-11	SELL	-1,548	18.810	18.910	18.900	USD -29,257	21.91 Profit of 4,666 on sale
2025-04-08	SELL	-771	16.960	18.405	18.261	USD -14,079	22.04 Profit of 2,915 on sale
2025-04-07	SELL	-556	17.720	18.670	18.575	USD -10,328	22.09 Profit of 1,955 on sale
2025-03-31	SELL	-514	17.750	17.870	17.858	USD -9,179	22.30 Profit of 2,281 on sale
2025-03-21	SELL	-510	19.320	19.360	19.356	USD -9,872	22.57 Profit of 1,638 on sale
2025-03-12	SELL	-260	18.920	19.030	19.019	USD -4,945	22.94 Profit of 1,020 on sale
2025-02-28	SELL	-259	22.150	22.230	22.222	USD -5,755	23.34 Profit of 290 on sale
2025-02-25	BUY	259	20.890	21.290	21.250	USD 5,504	23.46
2025-02-20	SELL	-258	23.380	24.560	24.442	USD -6,306	23.52 Loss of -239 on sale
2025-02-19	BUY	516	24.700	25.150	25.105	USD 12,954	23.49
2025-02-18	BUY	258	24.490	25.550	25.444	USD 6,565	23.48
2024-12-30	SELL	-493	21.180	21.350	21.333	USD -10,517	23.65 Profit of 1,144 on sale
2024-12-06	SELL	-253	25.040	25.500	25.454	USD -6,440	23.56 Loss of -480 on sale
2024-12-04	SELL	-253	25.920	26.370	26.325	USD -6,660	23.44 Loss of -730 on sale
2024-12-03	SELL	-506	24.960	25.690	25.617	USD -12,962	23.39 Loss of -1,128 on sale
2024-11-21	SELL	-258	22.580	22.850	22.823	USD -5,888	22.85 Profit of 6 on sale
2024-11-20	SELL	-265	22.370	22.540	22.523	USD -5,969	22.87 Profit of 93 on sale
2024-11-19	SELL	-265	22.060	22.300	22.276	USD -5,903	22.92 Profit of 171 on sale
2024-11-18	SELL	-1,020	21.560	22.035	21.987	USD -22,427	23.01 Profit of 1,038 on sale
2024-11-12	SELL	-255	23.320	23.960	23.896	USD -6,093	22.98 Loss of -232 on sale
2024-11-07	SELL	-255	23.880	24.240	24.204	USD -6,172	22.86 Loss of -342 on sale
2024-11-05	SELL	-510	22.900	23.364	23.318	USD -11,892	22.83 Loss of -249 on sale
2024-10-28	SELL	-255	22.890	23.640	23.565	USD -6,009	22.99 Loss of -146 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of CDNA

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	298,655	0	712,956	41.9%
2025-09-18	355,626	0	837,872	42.4%
2025-09-17	429,087	47	879,989	48.8%
2025-09-16	252,748	0	514,266	49.1%
2025-09-15	292,249	0	628,028	46.5%
2025-09-12	207,421	187	379,210	54.7%
2025-09-11	253,554	600	467,917	54.2%
2025-09-10	265,934	0	465,495	57.1%
2025-09-09	361,880	3,670	676,068	53.5%
2025-09-08	410,641	3	646,590	63.5%
2025-09-05	443,347	0	1,022,837	43.3%
2025-09-04	294,210	0	813,808	36.2%
2025-09-03	552,397	3,862	1,049,253	52.6%
2025-09-02	403,981	0	975,625	41.4%
2025-08-29	501,121	0	1,083,373	46.3%
2025-08-28	456,159	845	824,723	55.3%
2025-08-27	669,973	4,465	1,167,783	57.4%
2025-08-26	238,417	577	345,394	69.0%
2025-08-25	151,585	0	354,159	42.8%
2025-08-22	183,849	0	487,238	37.7%
2025-08-21	223,942	3	483,488	46.3%
2025-08-20	247,683	1,735	662,350	37.4%
2025-08-19	252,508	2,432	499,141	50.6%
2025-08-18	159,763	0	379,650	42.1%
2025-08-15	136,977	16	330,658	41.4%
2025-08-14	179,952	892	321,515	56.0%
2025-08-13	390,908	6,530	651,165	60.0%
2025-08-12	463,114	0	830,347	55.8%
2025-08-11	245,426	0	526,304	46.6%
2025-08-08	329,331	21,286	751,843	43.8%
2025-08-07	632,381	58,356	1,267,039	49.9%
2025-08-06	546,547	0	845,924	64.6%
2025-08-05	321,290	550	594,567	54.0%
2025-08-04	307,120	182	520,339	59.0%
2025-08-01	205,263	0	423,564	48.5%
2025-07-31	281,186	0	585,295	48.0%
2025-07-30	259,922	0	530,681	49.0%
2025-07-29	339,751	0	550,947	61.7%
2025-07-28	186,482	0	380,806	49.0%
2025-07-25	174,778	840	318,501	54.9%
2025-07-24	215,084	317	476,947	45.1%
2025-07-23	256,757	118	614,379	41.8%
2025-07-22	276,035	2,865	665,534	41.5%
2025-07-21	702,106	4,767	2,108,695	33.3%
2025-07-18	1,155,410	95,413	2,854,620	40.5%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares Healthcare Innovation UCITS ETF USD (Acc)
Issuer	Blackrock
Entity holding fund	iShares IV Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300ZP07LMR36K1T02
ETF Ticker	DRDR(GBX) LSE
ETF Ticker	2B78(EUR) F
ETF Ticker	2B78.DE(EUR) CXE
ETF Ticker	DRDR.LS(GBX) CXE
ETF Ticker	HEAL.AS(EUR) CXE
ETF Ticker	HEAL.LS(USD) CXE
ETF Ticker	HEALz(USD) CXE
ETF Ticker	HEAL(EUR) ETF Plus
ETF Ticker	DRDR.L(GBP) LSE